Pharmaceutical

Dr Abhijit Gothoskar, Technical Expert, Sigachi Industries

Dr Abhijit Gothoskar, Technical Expert, Sigachi Industries

Edusehat September 1, 2026 0 0

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Dr Abhijit Got...

Dr Ajay Jaysingh Khopade, Site Head R&D, VP and Head-Formulation and Analytical R&D, Sun Pharmaceutical Industries

Dr Ajay Jaysingh Khopade, Site Head R&D, VP and Head-Fo...

Edusehat September 1, 2026 0 0

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Dr Ajay Jaysin...

Ms Ritu Laddha, Sr VP & Cluster Head, Zydus Lifesciences

Ms Ritu Laddha, Sr VP & Cluster Head, Zydus Lifesciences

Edusehat September 1, 2026 0 0

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Ms Ritu Laddha...

Panel Discussion: AI, talent and technology: The new FR&D toolkit

Panel Discussion: AI, talent and technology: The new FR...

Edusehat September 1, 2026 0 0

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Panel Discuss...

Dr Richa Dayaramani, Scientist Grade F, NIPER Ahmedabad

Dr Richa Dayaramani, Scientist Grade F, NIPER Ahmedabad

Edusehat September 1, 2026 0 0

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Dr Richa Daya...

Panel Discussion: Ahmedabad’s innovation edge: Where science meets scale

Panel Discussion: Ahmedabad’s innovation edge: Where sc...

Edusehat September 1, 2026 0 0

FDD Conclave 2026 | 6th August 2026 | Ahmedabad Connect The post Panel Discuss...

BioE3 at 2: From policy push to industry scale

BioE3 at 2: From policy push to industry scale

Edusehat Agustus 31, 2026 0 0

Podcast with Dr. Rahul Warke, Ph.D., Director, Research and Development (Microb...

Teva Pharmaceuticals to acquire BioXcel assets for up to $125m

Teva Pharmaceuticals to acquire BioXcel assets for up t...

Edusehat Agustus 31, 2026 0 0

The agreement arises as part of BioXcel Therapeutics’ voluntary Chapter 11 proce...

AusperBio raises $120m to progress hepatitis B therapies

AusperBio raises $120m to progress hepatitis B therapies

Edusehat Agustus 31, 2026 0 0

The round was led by an undisclosed strategic investor. New investor RA Capital ...

Lannett launches generic Advair Diskus in US

Lannett launches generic Advair Diskus in US

Edusehat Agustus 31, 2026 0 0

Aurobindo Pharma USA subsidiary introduces fluticasone propionate and salmetero...

MetaG1 launches scientific discussion platform for pharma and life sciences

MetaG1 launches scientific discussion platform for phar...

Edusehat Agustus 31, 2026 0 0

Bengaluru-based initiative aims to preserve expert discussions on evidence, met...

Zydus reports positive Phase II(b) EVIDENCES-X results for Saroglitazar Mg in MASH

Zydus reports positive Phase II(b) EVIDENCES-X results ...

Edusehat Agustus 31, 2026 0 0

Global trial met its primary endpoint of MASH resolution without worsening of f...

Bombay HC directs Maharashtra FDA to withdraw Cipla licence cancellation order

Bombay HC directs Maharashtra FDA to withdraw Cipla lic...

Edusehat Agustus 31, 2026 0 0

Court questions FDA’s handling of proceedings and directs regulator to issue fr...

Maharashtra FDA cancels Cipla C&F drug sale licences in Pune

Maharashtra FDA cancels Cipla C&F drug sale licences in...

Edusehat Agustus 29, 2026 0 0

The action follows inspections in June 2026 involving Reactin Plus Tablets, a S...

FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911

FDA to review Kowa Pharmaceuticals’ NDA for glaucoma ey...

Edusehat Agustus 28, 2026 0 0

The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of 3...

Oviya MedSafe to host webinar on pharmacovigilance system for regulatory compliance in India

Oviya MedSafe to host webinar on pharmacovigilance syst...

Edusehat Agustus 28, 2026 0 0

Webinar will cover pharmacovigilance requirements, system elements and regulato...

12
13
14
15
16